DigitCells Unveils Proprietary TWO-D system at AUA 2024, Revolutionizing Pathology Workflows
CHICAGO, May 1, 2024 /PRNewswire-PRWeb/ -- DigitCells, a leading innovator in complete digital pathology solutions and a subsidiary company of GoPath Diagnostics, is excited to announce the launch of its groundbreaking Tissue Workflow Optimization for Digital (TWOD) system for prostate at the upcoming 2024 American Urological Association (AUA) Annual Meeting in San Antonio, Texas.
- The TWOD system represents a revolutionary leap in pathology workflows, delivering unprecedented efficiency gains and setting a new benchmark in digital pathology."
- Dr. Jim Lu, CEO and Medical Director of GoPath Diagnostics
The TWOD system streamlines biopsy tissue workflows, significantly enhancing efficiency to meet the demands of today's pathology environment. - This process is centrally managed by TWOD's LIS and IMS system which integrates laboratory information and pathology imaging with embedded augmented intelligence and pathology sign-out functions.
- The TWOD system bridges the gap between histopathology and digital pathology, reducing cost and improving workflow efficiency.